Financhill
Back

Protagonist Therapeutics Vs. Enphase Energy Industry Stock Comparison

Sell
48

PTGX
Protagonist Therapeutics

Last Price:
31.98
Seasonality Move:
-0.18%
Sell
24

ENPH
Enphase Energy

Last Price:
104.77
Seasonality Move:
8.35%
Sell
48
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $31.76. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Enphase Energy (ENPH) is a Sell

Is Enphase Energy a Buy, Sell or Hold?

  • The current Enphase Energy [ENPH] share price is $102.99. The Score for ENPH is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ENPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $31.76
    The current trend is moderately bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ENPH Stock Price Chart

What is Enphase Energy's stock price today?

  • The Enphase Energy share price today is $102.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.64 Buy
Relative Strength Index (14 RSI): 51.46 Buy
Chaikin Money Flow: 237349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.7 - 33.76) Buy
Bollinger Bands (100): (26.44 - 31.46) Buy

ENPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.84 Sell
Relative Strength Index (14 RSI): 34.78 Sell
Chaikin Money Flow: 3681369 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.3 - 132.06) Sell
Bollinger Bands (100): (109.25 - 126.75) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.2 Sell
20-day SMA: 31.94 Sell
50-day SMA: 29.45 Buy
200-day SMA: 24.03 Buy
8-day EMA: 32.16 Sell
20-day EMA: 31.88 Sell
50-day EMA: 30.39 Buy
200-day EMA: 25.87 Buy

ENPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 122.49 Sell
50-day SMA: 116.83 Sell
200-day SMA: 113.75 Sell
8-day EMA: 110.66 Sell
20-day EMA: 117.14 Sell
50-day EMA: 118.14 Sell
200-day EMA: 125.11 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.

Enphase Energy Earnings Growth & ENPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.32 per share, a decrease this year of $1.54 per share, and an increase next year of $2.25 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Enphase Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):